Suvretta Capital Management has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Avalyn Pharma's $100M Series B+ round in September 2023, which it led, alongside Wellington Management, Vida Ventures, T. Rowe Price and 6 others. That company is in Health and bio.

What Suvretta Capital Management invests in

• Health and bio · 1 · 100%

How Suvretta Capital Management invests

Share is of the 1 round on Recent Funding that name Suvretta Capital Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Suvretta Capital Management portfolio companies

• AAvalyn Pharma$100MSeries B+ · Sep 2023

Most frequent co-investors

• WWellington Management1 shared round · last Sep 27, 2023
• TT. Rowe Price1 shared round · last Sep 27, 2023
• RRock Springs Capital1 shared round · last Sep 27, 2023
• RRiverVest1 shared round · last Sep 27, 2023
• VVida Ventures1 shared round · last Sep 27, 2023
• TTPG Biotech1 shared round · last Sep 27, 2023
• SSurveyor Capital1 shared round · last Sep 27, 2023
• SSR One1 shared round · last Sep 27, 2023
• PPivotal bioVenture Partners1 shared round · last Sep 27, 2023

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• DDeepWork Capital1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Suvretta Capital Management, which is a subset of its real portfolio. API: /api/v1/investors/suvretta-capital-management (get a free API key). More: the most active VC firms and new venture capital funds.